Table 2.
Mice | WT | AT1a−/− | WT | AT1a−/− | P‡ |
---|---|---|---|---|---|
Cerulein | – | – | + | + | |
Abnormal architecture | 0 ± 0 | 0 ± 0 | 2.0 ± 0.7 | 2.8 ± 0.5 | 0.29 |
Glandula atrophy | 0 ± 0 | 0 ± 0 | 2.2 ± 0.8 | 2.8 ± 0.5 | 0.54 |
Psedotubular complexes | 0 ± 0 | 0 ± 0 | 2.4 ± 0.6 | 3.0 ± 0 | 0.20 |
Necrosis | 0 ± 0 | 0 ± 0 | 1.0 ± 0 | 1.25 ± 0.5 | 0.29 |
Total score of above | 0 ± 0 | 0 ± 0 | 1.95 ± 0.8 | 2.44 ± 0.8 | |
Acute inflammation* | 0 ± 0 | 0 ± 0 | 1.4 ± 0.6 | 1.75 ± 0.5 | 0.20 |
Chronic inflammation† | 0.5 ± 1.0 | 0 ± 0 | 2.4 ± 0.6 | 2.3 ± 0.5 | 0.85 |
Data are means ±SE (n = 4 mice per group).
For the acute inflammation, the content of acute inflammatory cells (neutrophils) was graded, and
for the chronic inflammation, the content of mononuclear cells was graded. For the description of the histopathology score see materials and methods.
P values were calculated between cerulein-treated wild-type (WT) and AT1a−/− groups.